Spinal cord injury (SCI) causes paralysis in roughly one million people worldwide, with incident cases rising yearly. Beyond motor and sensory deficits, patients frequently experience muscle atrophy, ...

Spasticity most often develops in upper motor neuron types of injuries. It is a motor disorder defined as velocity dependent, increased resistance to passive muscle stretch. It is an exaggeration of ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Oral spray containing two compounds ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

The Food and Drug Administration has approved expanded use of Dysport to treat upper- and lower-limb spasticity – including that caused by cerebral palsy – for patients as young as 2 years and older, ...